To examine whether IMP3 is responsible to maintain reduced levels of the anti-apoptotic Bcl molecules in CRC, we explored Bcl-2 and Bcl-xL expression in HCT-116 cell line treated with or without IMP3 siRNA. Here, BCL2 is linked to colorectal carcinoma.